beta-Hydroxy beta-methylbutyric acid
150px | |
Names | |
---|---|
IUPAC name
3-hydroxy-3-methylbutanoic acid
|
|
Other names
β-Hydroxyisovaleric acid
3-Hydroxyisovaleric acid |
|
Identifiers | |
625-08-1 ![]() |
|
Abbreviations | HMB |
ChEBI | CHEBI:37084 ![]() |
ChemSpider | 62571 ![]() |
Jmol 3D model | Interactive image |
PubChem | 69362 |
UNII | 3F752311CD ![]() |
|
|
|
|
Properties | |
C5H10O3 | |
Molar mass | 118.131 g/mol |
Density | 0.938 g/mL |
Melting point | −80 °C (−112 °F; 193 K) |
Boiling point | 88 °C (190 °F; 361 K) at 1 mmHg |
Vapor pressure | {{{value}}} |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
![]() ![]() ![]() |
|
Infobox references | |
β-Hydroxy β-methylbutyric acid (HMB), or β-hydroxy β-methylbutyrate, is a metabolite of the essential amino acid leucine and is synthesized in the human body. Its part in protein synthesis was discovered by Steven L. Nissen at Iowa State University.[2] It has been used in scientific studies to purportedly increase muscle mass and decrease muscle breakdown. Nissen held the original patent on the metabolite as a nutritional supplement. It was discovered in pigs and small quantities can also be found in grapefruit, alfalfa, and catfish. As a supplement it is usually sold as the calcium salt calcium beta-hydroxy-beta-methylbutyrate.
Research published in the Journal of Applied Physiology has shown that HMB may have an effect on increasing muscle weight and strength.[2] A review in Nutrition & Metabolism provides an in depth and objective analysis of HMB research. [3] The same study lists as HMB's proposed mechanisms of action the following:
- Increased sarcolemmal integrity via conversion to HMG-CoA
- Enhanced protein synthesis via the mTOR pathway
- Depression of protein degradation through inhibition of the ubiquitin pathway
The human body produces about 0.2-0.4 grams per day. Standard doses in research studies have been 1.5 to 3.0 grams per day, usually divided into two doses. Toxicity at these doses is unlikely, as the no-observed-adverse-event-level (NOAEL) in rats is between 2.48 to 2.83 g/kg BW per day, roughly equivalent to 70 to 100 g/day in humans.[4]
References
- ↑ β-Hydroxyisovaleric acid at Sigma-Aldrich
- ↑ 2.0 2.1 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.